Skip to search formSkip to main contentSkip to account menu

Luminal B Breast Carcinoma

Known as: Luminal B, Luminal B Subtype of Breast Carcinoma, Luminal B Estrogen Receptor Positive Subtype of Breast Carcinoma 
A biologic subset of breast carcinoma defined by low to moderate expression of genes characteristic of luminal epithelial cells including estrogen… 
National Institutes of Health

Related topics

Related topics

8 relations
BreastEpithelial CellsEpitheliumMalignant Epithelial Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A Versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status.
OBJECTIVE The purpose of this study is to assess whether luminal A versus luminal B molecular subtypes of breast cancer affect… 
2016
2016
Abstract 1598: LncRNA AK001796 as a therapeutic target in aggressive breast cancers
Breast cancer is a heterogeneous disease that can be classified into several distinct molecular subtypes based on gene expression… 
2015
2015
Risikofaktoren und Prävention des Mammakarzinoms
ZusammenfassungHintergrundNeben Brustkrebsrisikofaktoren wie Hormoneinfluss, Reproduktionsverhalten und Lifestylefaktoren führen… 
2014
2014
Intrinsic Subtypes from the PAM 50 Gene Expression Assay in a Population-Based Breast Cancer Survivor Cohort : Prognostication of Short-and Long-term Outcomes
Background:ThePAM50, agene expression assay to categorize breast tumors into intrinsic subtypes, hasnot been previously used to… 
2013
2013
The Prognostic Significance of the Luminal A, Luminal B, Basal and Her 2 Neu Subtypes of Breast Cancer in Saudi Women
Background: Breast Cancer (BC) is molecularly diverse disease that has been sub-classified in four major subtypes; (a) luminal A… 
2011
2011
S2-2: Luminal A Subtype Predicts Radiation Response in Patients with T1N0 Breast Cancer Enrolled in a Randomized Trial of Tamoxifen with or without Breast Radiation.
Objectives To determine the predictive effect of molecular subtyping using the six biomarker immunohistochemical panel in… 
2010
2010
CSPG 4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
  • 2010
  • Corpus ID: 102497029
Based on gene expression profiling using the DNA microarray technology, breast tumors are classified into distinct molecular… 
2010
2010
[Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].
OBJECTIVE To investigate the expression of FOXA1 in breast invasive ductal carcinomas, observe its expression in all molecular… 
2008
2008
A supervised risk predictor of breast cancer based on biological subtypes
11008 Background: The biological subtypes of breast cancer designated as Luminal A (LumA), Luminal B (LumB), HER2, and Basal have… 
2008
2008
Breast cancer molecular subtypes and locoregional recurrence
510 Background: Gene expression profiling studies have consistently revealed prognostically significant breast cancer subtypes… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)